Jiangxi Synergy Pharmaceutical Co., Ltd.
SZSE:300636.SZ
10.41 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 175.597 | 205.596 | 162.477 | 177.908 | 161.008 | 220.746 | 191.633 | 192.3 | 156.204 | 179.771 | 164.126 | 150.471 | 140.183 | 137.347 | 96.099 | 102.168 | 140.469 | 96.684 | 131.805 | 86.221 | 113.254 | 81.778 | 79.728 | 61.576 | 54.047 | 71.773 | 74.342 | 69.389 | 87.775 | 65.21 | 75.466 | 53.539 | 63.177 | 57.897 | 73.569 | 73.569 | 63.838 | 63.838 |
Cost of Revenue
| 119.383 | 130.755 | 97.092 | 130.065 | 112.979 | 141.522 | 113.034 | 131.995 | 116.818 | 124.609 | 114.362 | 103.041 | 97.785 | 98.084 | 61.633 | 64.403 | 95.631 | 61.602 | 94.807 | 55.035 | 77.463 | 62.898 | 54.325 | 42.965 | 38.167 | 53.481 | 49.157 | 45.42 | 53.674 | 39.877 | 47.939 | 34.17 | 39.12 | 32.035 | 45.344 | 45.344 | 37.432 | 37.432 |
Gross Profit
| 56.213 | 74.841 | 65.385 | 47.843 | 48.029 | 79.225 | 78.599 | 60.305 | 39.386 | 55.163 | 49.764 | 47.43 | 42.398 | 39.263 | 34.466 | 37.766 | 44.838 | 35.082 | 36.998 | 31.186 | 35.791 | 18.88 | 25.403 | 18.61 | 15.881 | 18.292 | 25.185 | 23.968 | 34.101 | 25.333 | 27.526 | 19.369 | 24.057 | 25.862 | 28.225 | 28.225 | 26.406 | 26.406 |
Gross Profit Ratio
| 0.32 | 0.364 | 0.402 | 0.269 | 0.298 | 0.359 | 0.41 | 0.314 | 0.252 | 0.307 | 0.303 | 0.315 | 0.302 | 0.286 | 0.359 | 0.37 | 0.319 | 0.363 | 0.281 | 0.362 | 0.316 | 0.231 | 0.319 | 0.302 | 0.294 | 0.255 | 0.339 | 0.345 | 0.389 | 0.388 | 0.365 | 0.362 | 0.381 | 0.447 | 0.384 | 0.384 | 0.414 | 0.414 |
Reseach & Development Expenses
| 11.889 | 10.292 | 15.674 | 8.949 | 19.318 | 19.21 | 19.605 | 15.609 | 14.201 | 11.497 | 14.698 | 9.683 | 7.811 | 6.829 | 12.501 | 7.634 | 7.572 | 7.593 | 17.038 | 7.835 | 5.724 | 5.737 | 9.553 | 6.479 | 13.676 | 4.979 | 15.723 | 3.362 | 5.956 | 0 | 12.74 | 0 | 6.511 | 0 | 3.865 | 3.85 | 3.331 | 3.331 |
General & Administrative Expenses
| -5.354 | 8.398 | -22.076 | 25.882 | -6.985 | 9.061 | -16.337 | 19.667 | -5.126 | 6.586 | -9.702 | 12.955 | -2.364 | 4.527 | -8.041 | 4.154 | -2.655 | 3.8 | -7.656 | 4.074 | -2.064 | 4.456 | -1.812 | 6.092 | -7.418 | 9.427 | -17.2 | 7.568 | -3.849 | 6.774 | -15.835 | 5.931 | 7.726 | 5.934 | 7.718 | 7.718 | 6.634 | 6.634 |
Selling & Marketing Expenses
| 6.735 | 5.926 | 8.694 | 5.724 | 6.536 | 5.3 | 6.053 | 3.331 | 4.026 | 5.059 | 4.732 | 5.633 | 3.639 | 4.024 | 4.073 | 3.582 | 3.499 | 2.699 | 4.323 | 2.932 | 3.127 | 2.689 | 4.253 | 2.563 | 2.725 | 1.816 | 2.7 | 2.471 | 2.281 | 2.017 | 2.466 | 3.798 | 2.556 | 1.595 | 2.767 | 2.767 | 2.155 | 2.155 |
SG&A
| 1.381 | 16.849 | -13.381 | 31.606 | -0.449 | 14.361 | -10.284 | 22.998 | -1.099 | 11.645 | -4.97 | 18.588 | 1.274 | 8.551 | -3.968 | 7.736 | 0.845 | 6.499 | -3.333 | 7.006 | 1.063 | 7.146 | 2.442 | 8.654 | -4.694 | 11.243 | -14.5 | 10.039 | -1.568 | 8.791 | -13.369 | 9.73 | 10.282 | 7.528 | 10.625 | 10.625 | 8.919 | 8.919 |
Other Expenses
| 0.197 | -7.921 | 0.327 | 1.503 | 3.068 | 0.503 | 26.689 | -11.959 | 10.095 | 0.268 | 18.068 | -7.367 | 6.745 | -0.343 | 13.08 | -1.7 | 5.38 | -0.19 | -0.05 | 0.235 | 5.222 | 0.052 | 12.583 | 0 | 0.01 | 0.034 | -5.214 | 5.47 | 1.151 | 0.413 | 6.901 | 0.946 | 1.044 | 0.408 | 0 | 0 | 0 | 0 |
Operating Expenses
| 28.909 | 35.063 | 31.291 | 24.223 | 28.27 | 34.074 | 36.009 | 26.648 | 23.196 | 23.411 | 27.796 | 20.904 | 15.83 | 15.037 | 21.613 | 13.671 | 13.798 | 13.668 | 22.116 | 15.077 | 12.009 | 12.598 | 24.578 | 15.071 | 4.388 | 11.736 | 6.19 | 9.888 | 9.738 | 9.425 | 9.581 | 10.056 | 10.83 | 7.846 | 8.157 | 8.157 | 7.987 | 7.987 |
Operating Income
| 28.176 | 39.778 | 23.013 | 28.086 | 26.115 | 35.018 | 26.707 | 34.414 | 15.655 | 29.557 | 14.723 | 26.622 | 24.925 | 22.07 | 9.172 | 21.217 | 29.981 | 17.879 | 5.077 | 16.56 | 25.571 | 4.473 | -2.128 | 6.496 | 14.919 | 6.995 | 19.697 | 15.77 | 21.949 | 15.369 | 19.064 | 9.01 | 13.076 | 17.239 | 17.037 | 17.037 | 16.741 | 16.741 |
Operating Income Ratio
| 0.16 | 0.193 | 0.142 | 0.158 | 0.162 | 0.159 | 0.139 | 0.179 | 0.1 | 0.164 | 0.09 | 0.177 | 0.178 | 0.161 | 0.095 | 0.208 | 0.213 | 0.185 | 0.039 | 0.192 | 0.226 | 0.055 | -0.027 | 0.105 | 0.276 | 0.097 | 0.265 | 0.227 | 0.25 | 0.236 | 0.253 | 0.168 | 0.207 | 0.298 | 0.232 | 0.232 | 0.262 | 0.262 |
Total Other Income Expenses Net
| 5.622 | 9.187 | 0.327 | 4.447 | 10.576 | -0.059 | -0.15 | 2.467 | -2.19 | -0.033 | -1.273 | -0.854 | 0 | 0.751 | 2.536 | -3.671 | -2.547 | -0.19 | -0.05 | -0.242 | 0.548 | 0.052 | 7.673 | 0 | 0.01 | 0.034 | -5.214 | 5.47 | 1.151 | 0.413 | 6.727 | 0.946 | 1.044 | 0.408 | 2.327 | 2.327 | 0.183 | 0.183 |
Income Before Tax
| 28.176 | 48.965 | 23.34 | 28.086 | 26.115 | 34.959 | 26.557 | 34.414 | 15.655 | 29.524 | 14.723 | 26.622 | 24.925 | 22.07 | 9.172 | 21.217 | 29.981 | 17.689 | 5.027 | 16.56 | 25.571 | 4.526 | -2.128 | 6.496 | 14.929 | 7.028 | 14.483 | 21.24 | 23.099 | 15.781 | 25.791 | 9.956 | 14.12 | 17.647 | 19.364 | 19.364 | 16.925 | 16.925 |
Income Before Tax Ratio
| 0.16 | 0.238 | 0.144 | 0.158 | 0.162 | 0.158 | 0.139 | 0.179 | 0.1 | 0.164 | 0.09 | 0.177 | 0.178 | 0.161 | 0.095 | 0.208 | 0.213 | 0.183 | 0.038 | 0.192 | 0.226 | 0.055 | -0.027 | 0.105 | 0.276 | 0.098 | 0.195 | 0.306 | 0.263 | 0.242 | 0.342 | 0.186 | 0.224 | 0.305 | 0.263 | 0.263 | 0.265 | 0.265 |
Income Tax Expense
| 2.187 | 5.402 | -3.99 | 6.464 | 2.181 | 1.862 | 0.376 | 2.566 | -0.156 | 2.696 | 0.15 | 2.605 | 2.534 | 1.932 | -0.381 | 2.458 | 4.033 | 1.898 | -1.401 | 1.483 | 3.237 | 0.055 | -0.442 | -0.001 | 1.283 | 0.954 | 0.604 | 3.05 | 3.09 | 2.402 | 3.299 | 1.872 | 1.67 | 2.677 | 2.526 | 2.526 | 2.323 | 2.323 |
Net Income
| 25.989 | 43.563 | 27.33 | 21.622 | 23.934 | 33.096 | 26.181 | 31.848 | 15.81 | 26.828 | 14.573 | 24.018 | 22.391 | 20.138 | 9.552 | 18.76 | 25.948 | 15.791 | 6.428 | 15.076 | 22.334 | 4.47 | -1.686 | 6.497 | 13.646 | 6.074 | 13.878 | 18.19 | 20.01 | 13.379 | 22.492 | 8.084 | 12.45 | 14.97 | 16.838 | 16.838 | 14.602 | 14.602 |
Net Income Ratio
| 0.148 | 0.212 | 0.168 | 0.122 | 0.149 | 0.15 | 0.137 | 0.166 | 0.101 | 0.149 | 0.089 | 0.16 | 0.16 | 0.147 | 0.099 | 0.184 | 0.185 | 0.163 | 0.049 | 0.175 | 0.197 | 0.055 | -0.021 | 0.106 | 0.252 | 0.085 | 0.187 | 0.262 | 0.228 | 0.205 | 0.298 | 0.151 | 0.197 | 0.259 | 0.229 | 0.229 | 0.229 | 0.229 |
EPS
| 0.062 | 0.1 | 0.12 | 0.052 | 0.069 | 0.096 | 0.076 | 0.14 | 0.07 | 0.079 | 0.071 | 0.11 | 0.099 | 0.065 | 0.046 | 0.061 | 0.13 | 0.082 | 0.05 | 0.049 | 0.11 | 0.015 | -0.008 | 0.021 | 0.067 | 0.02 | 0.067 | 0.082 | 0.099 | 0.059 | 0.14 | 0.034 | 0.078 | 0.065 | 0.073 | 0.073 | 0.07 | 0.07 |
EPS Diluted
| 0.062 | 0.1 | 0.12 | 0.052 | 0.068 | 0.094 | 0.059 | 0.14 | 0.07 | 0.079 | 0.065 | 0.11 | 0.099 | 0.065 | 0.046 | 0.061 | 0.13 | 0.082 | 0.05 | 0.049 | 0.11 | 0.015 | -0.008 | 0.021 | 0.067 | 0.02 | 0.067 | 0.082 | 0.099 | 0.059 | 0.14 | 0.034 | 0.078 | 0.065 | 0.073 | 0.073 | 0.07 | 0.07 |
EBITDA
| 37.434 | 63.474 | 44.072 | 30.199 | 24.951 | 43.53 | 41.469 | 34.429 | 14.595 | 32.573 | 22.346 | 26.388 | 27.41 | 25.488 | 13.549 | 22.596 | 31.056 | 20.999 | 14.416 | 17.373 | 25.289 | 5.627 | 1.326 | 3.759 | 14.94 | 6.302 | 22.111 | 12.651 | 23.494 | 15.908 | 28.326 | 9.313 | 13.227 | 18.015 | 29.921 | 17.748 | 17.563 | 17.563 |
EBITDA Ratio
| 0.213 | 0.309 | 0.271 | 0.17 | 0.155 | 0.197 | 0.216 | 0.179 | 0.093 | 0.181 | 0.136 | 0.175 | 0.196 | 0.186 | 0.141 | 0.221 | 0.221 | 0.217 | 0.109 | 0.201 | 0.223 | 0.069 | 0.017 | 0.061 | 0.276 | 0.088 | 0.297 | 0.182 | 0.268 | 0.244 | 0.375 | 0.174 | 0.209 | 0.311 | 0.407 | 0.241 | 0.275 | 0.275 |